BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu F, Wang Y, Xu Z, Qu H, Zhang H, Niu L, Xue H, Jing D, He H. Novel adeno‑associated virus‑based genetic vaccines encoding hepatitis C virus E2 glycoprotein elicit humoral immune responses in mice. Mol Med Rep 2019;19:1016-23. [PMID: 30569131 DOI: 10.3892/mmr.2018.9739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Butkovich N, Li E, Ramirez A, Burkhardt AM, Wang SW. Advancements in protein nanoparticle vaccine platforms to combat infectious disease. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1681. [PMID: 33164326 DOI: 10.1002/wnan.1681] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Zhan W, Muhuri M, Tai PWL, Gao G. Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens? Front Immunol 2021;12:673699. [PMID: 34046041 DOI: 10.3389/fimmu.2021.673699] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Stagg SM, Yoshioka C, Davulcu O, Chapman MS. Cryo-electron Microscopy of Adeno-associated Virus. Chem Rev 2022. [PMID: 35575684 DOI: 10.1021/acs.chemrev.1c00936] [Reference Citation Analysis]
4 Cohen AC, Roane BM, Leath CA 3rd. Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy. Drugs 2020;80:217-27. [PMID: 31939072 DOI: 10.1007/s40265-019-01249-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]